Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith M Boer

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
The Lancet. Haematology|December 28, 2020
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort studyMonique L den Boer, Gunnar Cario, Anthony V Moorman, et al.
Leukemia|December 20, 2024
PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcomeAurélie Caye-Eude, Grazia Fazio, Agata Pastorczak, et al.
Blood|April 8, 2024
Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphomaEmma Kroeze, Ingram Iaccarino, Michelle M Kleisman, et al.
EMBO Molecular Medicine|January 4, 2024
Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progressionOscar Molina, Carmen Ortega-Sabater, Namitha Thampi, et al.
Blood|March 22, 2024
The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosisLennart Lenk, Irène Baccelli, Anna Laqua, et al.
Hemasphere|April 20, 2026
Biological and clinical characteristics of <i>ETV6</i>::<i>RUNX1</i>-like ALLMarketa Zaliova, Dagmar Schinnerl, Judith M Boer, et al.
Leukemia|July 2, 2021
Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international studyJudith M Boer, Maria Grazia Valsecchi, Femke M Hormann, et al.
Leukemia|April 26, 2022
Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trialEdoardo Pennesi, Naomi Michels, Erica Brivio, et al.
Blood Advances|January 4, 2018
Intragenic amplification of <i>PAX5</i>: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?Claire Schwab, Karin Nebral, Lucy Chilton, et al.
Blood Advances|January 18, 2019
Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALLLina Hamadeh, Amir Enshaei, Claire Schwab, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
The Lancet. Haematology|December 28, 2020
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort studyMonique L den Boer, Gunnar Cario, Anthony V Moorman, et al.
Leukemia|December 20, 2024
PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcomeAurélie Caye-Eude, Grazia Fazio, Agata Pastorczak, et al.
Blood|April 8, 2024
Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphomaEmma Kroeze, Ingram Iaccarino, Michelle M Kleisman, et al.
EMBO Molecular Medicine|January 4, 2024
Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progressionOscar Molina, Carmen Ortega-Sabater, Namitha Thampi, et al.
Blood|March 22, 2024
The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosisLennart Lenk, Irène Baccelli, Anna Laqua, et al.
Hemasphere|April 20, 2026
Biological and clinical characteristics of <i>ETV6</i>::<i>RUNX1</i>-like ALLMarketa Zaliova, Dagmar Schinnerl, Judith M Boer, et al.
Leukemia|July 2, 2021
Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international studyJudith M Boer, Maria Grazia Valsecchi, Femke M Hormann, et al.
Leukemia|April 26, 2022
Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trialEdoardo Pennesi, Naomi Michels, Erica Brivio, et al.
Blood Advances|January 4, 2018
Intragenic amplification of <i>PAX5</i>: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?Claire Schwab, Karin Nebral, Lucy Chilton, et al.
Blood Advances|January 18, 2019
Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALLLina Hamadeh, Amir Enshaei, Claire Schwab, et al.
Pageof 10